![Kevin Driscoll-Lind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Driscoll-Lind
Vorstandsvorsitzender bei
APNIMED, INC.
Vermögen: - $ am 30.09.2026
Profil
Kevin R.
Driscoll-Lind is the founder of Perceptual Robotics Ltd., founded in 2016, serving as Chief Technology Officer.
Current jobs include Chief Executive Officer & Director at Apnimed, Inc. starting in 2026, Director at Avalo Therapeutics, Inc. starting in 2025, and Director at Cavalry Biosciences, Inc. Former jobs include Director at Longboard Pharmaceuticals, Inc. from 2020 to 2024, Director at Ceek Women's Health, Inc. from 2021 to 2024, Principal at Lehman Brothers, Inc., Chief Financial Officer & Executive Vice President at Arena Pharmaceuticals, Inc. from 2016 to 2020, Principal at Axon Capital LP in 2007, Vice President at Tarrant Capital IP LLC, and Principal at TPG Special Situations Partners LLC from 2009 to 2016.
Education includes undergraduate studies at Stanford University and an MBA from UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APNIMED, INC. -.--% | 03.08.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| 30.09.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von Kevin Driscoll-Lind
| Unternehmen | Position | Beginn |
|---|---|---|
| APNIMED, INC. | Vorstandsvorsitzender | 02.06.2026 |
| AVALO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.10.2025 |
Perceptual Robotics Ltd.
 Perceptual Robotics Ltd. Aerospace & DefenseElectronic Technology Develops unmanned aerial vehicle for wind turbine inspection | Gründer | 01.01.2016 |
Cavalry Biosciences, Inc.
 Cavalry Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kevin Driscoll-Lind
| Unternehmen | Position | Ende |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 02.12.2024 |
Ceek Women's Health, Inc.
 Ceek Women's Health, Inc. Medical SpecialtiesHealth Technology Develops obstetrics and gynecology medical devices & sells through online | Direktor/Vorstandsmitglied | 01.01.2024 |
| ARENA PHARMACEUTICALS | Finanzdirektor/CFO | 26.02.2020 |
TPG Special Situations Partners LLC
 TPG Special Situations Partners LLC Finance/Rental/LeasingFinance Provides financial services | Corporate Officer/Principal | 01.06.2016 |
Axon Capital LP
 Axon Capital LP Investment ManagersFinance Axon focuses on fundamental long/short investing across all geographies primarily through equity securities. | Corporate Officer/Principal | 31.12.2007 |
Ausbildung von Kevin Driscoll-Lind
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axon Capital LP
Axon Capital LP Investment ManagersFinance Axon focuses on fundamental long/short investing across all geographies primarily through equity securities. | Finance |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Operates as an alternative asset management firm | Finance |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TPG Special Situations Partners LLC
TPG Special Situations Partners LLC Finance/Rental/LeasingFinance Provides financial services | Finance |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases | Health Technology |
Perceptual Robotics Ltd.
Perceptual Robotics Ltd. Aerospace & DefenseElectronic Technology Develops unmanned aerial vehicle for wind turbine inspection | Electronic Technology |
Ceek Women's Health, Inc.
Ceek Women's Health, Inc. Medical SpecialtiesHealth Technology Develops obstetrics and gynecology medical devices & sells through online | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Cavalry Biosciences, Inc.
Cavalry Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Commercial Services |
